vs

Side-by-side financial comparison of BRIGHT HORIZONS FAMILY SOLUTIONS INC. (BFAM) and CABOT CORP (CBT). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $733.7M, roughly 1.2× BRIGHT HORIZONS FAMILY SOLUTIONS INC.). On growth, BRIGHT HORIZONS FAMILY SOLUTIONS INC. posted the faster year-over-year revenue change (8.8% vs -11.1%). BRIGHT HORIZONS FAMILY SOLUTIONS INC. produced more free cash flow last quarter ($258.5M vs $57.0M). Over the past eight quarters, BRIGHT HORIZONS FAMILY SOLUTIONS INC.'s revenue compounded faster (8.5% CAGR vs -8.7%).

Bright Horizons Family Solutions Inc. is a United States–based child-care provider and is the largest provider of employer-sponsored child care. It also provides back-up child care and elder care, tuition program management, education advising, and student loan repayment programs. It is headquartered in Newton, Massachusetts.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

BFAM vs CBT — Head-to-Head

Bigger by revenue
CBT
CBT
1.2× larger
CBT
$849.0M
$733.7M
BFAM
Growing faster (revenue YoY)
BFAM
BFAM
+19.9% gap
BFAM
8.8%
-11.1%
CBT
More free cash flow
BFAM
BFAM
$201.5M more FCF
BFAM
$258.5M
$57.0M
CBT
Faster 2-yr revenue CAGR
BFAM
BFAM
Annualised
BFAM
8.5%
-8.7%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BFAM
BFAM
CBT
CBT
Revenue
$733.7M
$849.0M
Net Profit
$73.0M
Gross Margin
19.3%
24.9%
Operating Margin
6.2%
15.2%
Net Margin
8.6%
Revenue YoY
8.8%
-11.1%
Net Profit YoY
-21.5%
EPS (diluted)
$0.38
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFAM
BFAM
CBT
CBT
Q4 25
$733.7M
$849.0M
Q3 25
$802.8M
$899.0M
Q2 25
$731.6M
$923.0M
Q1 25
$665.5M
$936.0M
Q4 24
$674.1M
$955.0M
Q3 24
$719.1M
$1.0B
Q2 24
$670.1M
$1.0B
Q1 24
$622.7M
$1.0B
Net Profit
BFAM
BFAM
CBT
CBT
Q4 25
$73.0M
Q3 25
$78.6M
$43.0M
Q2 25
$54.8M
$101.0M
Q1 25
$38.0M
$94.0M
Q4 24
$93.0M
Q3 24
$54.9M
$137.0M
Q2 24
$39.2M
$109.0M
Q1 24
$17.0M
$84.0M
Gross Margin
BFAM
BFAM
CBT
CBT
Q4 25
19.3%
24.9%
Q3 25
27.0%
24.5%
Q2 25
25.0%
26.4%
Q1 25
23.4%
25.7%
Q4 24
20.8%
24.6%
Q3 24
25.2%
24.0%
Q2 24
24.2%
25.2%
Q1 24
21.7%
24.1%
Operating Margin
BFAM
BFAM
CBT
CBT
Q4 25
6.2%
15.2%
Q3 25
15.1%
15.2%
Q2 25
11.8%
18.1%
Q1 25
9.4%
17.3%
Q4 24
7.2%
16.2%
Q3 24
12.4%
15.0%
Q2 24
10.3%
16.9%
Q1 24
6.4%
15.3%
Net Margin
BFAM
BFAM
CBT
CBT
Q4 25
8.6%
Q3 25
9.8%
4.8%
Q2 25
7.5%
10.9%
Q1 25
5.7%
10.0%
Q4 24
9.7%
Q3 24
7.6%
13.7%
Q2 24
5.8%
10.7%
Q1 24
2.7%
8.2%
EPS (diluted)
BFAM
BFAM
CBT
CBT
Q4 25
$0.38
$1.37
Q3 25
$1.37
$0.80
Q2 25
$0.95
$1.86
Q1 25
$0.66
$1.69
Q4 24
$0.50
$1.67
Q3 24
$0.94
$2.41
Q2 24
$0.67
$1.94
Q1 24
$0.29
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFAM
BFAM
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$140.1M
$230.0M
Total DebtLower is stronger
$747.6M
Stockholders' EquityBook value
$1.3B
$1.6B
Total Assets
$3.9B
$3.8B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFAM
BFAM
CBT
CBT
Q4 25
$140.1M
$230.0M
Q3 25
$116.6M
$258.0M
Q2 25
$179.2M
$239.0M
Q1 25
$112.0M
$213.0M
Q4 24
$110.3M
$183.0M
Q3 24
$109.9M
$223.0M
Q2 24
$140.2M
$197.0M
Q1 24
$63.7M
$206.0M
Total Debt
BFAM
BFAM
CBT
CBT
Q4 25
$747.6M
Q3 25
$747.5M
$1.1B
Q2 25
$797.0M
Q1 25
$872.7M
Q4 24
$918.4M
Q3 24
$925.7M
$1.1B
Q2 24
$931.9M
Q1 24
$938.1M
Stockholders' Equity
BFAM
BFAM
CBT
CBT
Q4 25
$1.3B
$1.6B
Q3 25
$1.4B
$1.6B
Q2 25
$1.4B
$1.5B
Q1 25
$1.3B
$1.4B
Q4 24
$1.3B
$1.4B
Q3 24
$1.4B
$1.4B
Q2 24
$1.3B
$1.3B
Q1 24
$1.2B
$1.4B
Total Assets
BFAM
BFAM
CBT
CBT
Q4 25
$3.9B
$3.8B
Q3 25
$3.9B
$3.8B
Q2 25
$3.9B
$3.8B
Q1 25
$3.8B
$3.8B
Q4 24
$3.9B
$3.6B
Q3 24
$3.9B
$3.7B
Q2 24
$3.8B
$3.6B
Q1 24
$3.8B
$3.6B
Debt / Equity
BFAM
BFAM
CBT
CBT
Q4 25
0.56×
Q3 25
0.52×
0.70×
Q2 25
0.57×
Q1 25
0.66×
Q4 24
0.72×
Q3 24
0.66×
0.75×
Q2 24
0.73×
Q1 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFAM
BFAM
CBT
CBT
Operating Cash FlowLast quarter
$350.7M
$126.0M
Free Cash FlowOCF − Capex
$258.5M
$57.0M
FCF MarginFCF / Revenue
35.2%
6.7%
Capex IntensityCapex / Revenue
12.6%
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$402.4M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFAM
BFAM
CBT
CBT
Q4 25
$350.7M
$126.0M
Q3 25
$-17.6M
$219.0M
Q2 25
$134.2M
$249.0M
Q1 25
$86.2M
$73.0M
Q4 24
$337.5M
$124.0M
Q3 24
$-8.9M
$204.0M
Q2 24
$109.4M
$207.0M
Q1 24
$116.3M
$176.0M
Free Cash Flow
BFAM
BFAM
CBT
CBT
Q4 25
$258.5M
$57.0M
Q3 25
$-42.4M
$155.0M
Q2 25
$115.4M
$188.0M
Q1 25
$70.9M
$1.0M
Q4 24
$240.2M
$47.0M
Q3 24
$-32.2M
$112.0M
Q2 24
$86.8M
$155.0M
Q1 24
$96.9M
$133.0M
FCF Margin
BFAM
BFAM
CBT
CBT
Q4 25
35.2%
6.7%
Q3 25
-5.3%
17.2%
Q2 25
15.8%
20.4%
Q1 25
10.7%
0.1%
Q4 24
35.6%
4.9%
Q3 24
-4.5%
11.2%
Q2 24
13.0%
15.3%
Q1 24
15.6%
13.1%
Capex Intensity
BFAM
BFAM
CBT
CBT
Q4 25
12.6%
8.1%
Q3 25
3.1%
7.1%
Q2 25
2.6%
6.6%
Q1 25
2.3%
7.7%
Q4 24
14.4%
8.1%
Q3 24
3.2%
9.2%
Q2 24
3.4%
5.1%
Q1 24
3.1%
4.2%
Cash Conversion
BFAM
BFAM
CBT
CBT
Q4 25
1.73×
Q3 25
-0.22×
5.09×
Q2 25
2.45×
2.47×
Q1 25
2.26×
0.78×
Q4 24
1.33×
Q3 24
-0.16×
1.49×
Q2 24
2.79×
1.90×
Q1 24
6.85×
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BFAM
BFAM

Segment breakdown not available.

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons